Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Accenture
Chubb
Chinese Patent Office
McKinsey
Harvard Business School
Cantor Fitzgerald
US Army
Citi
Queensland Health

Generated: January 18, 2018

DrugPatentWatch Database Preview

Rivastigmine tartrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for rivastigmine tartrate and what is the scope of rivastigmine tartrate freedom to operate?

Rivastigmine tartrate
is the generic ingredient in two branded drugs marketed by Novartis, Ajanta Pharma Ltd, Alembic Pharms Ltd, Apotex Inc, Aurobindo Pharma Ltd, Cadila Pharms Ltd, Dr Reddys Labs Inc, Macleods Pharms Ltd, Orchid Hlthcare, Sun Pharm Inds Ltd, and Watson Labs, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for rivastigmine tartrate. Twenty suppliers are listed for this compound. There is one tentative approval for this compound.
Pharmacology for rivastigmine tartrate
Tentative approvals for RIVASTIGMINE TARTRATE
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe2MG/MLSOLUTION; ORAL

US Patents and Regulatory Information for rivastigmine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orchid Hlthcare RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 090879-002 Jun 10, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Inc RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 077130-003 Oct 31, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 077129-003 Jan 8, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 077129-004 Jan 8, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cadila Pharms Ltd RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 203844-004 Feb 13, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Inc RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 077130-001 Oct 31, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 091072-001 May 16, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 204572-003 Mar 25, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 091072-002 May 16, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis EXELON rivastigmine tartrate CAPSULE;ORAL 020823-005 Apr 21, 2000 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for rivastigmine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis EXELON rivastigmine tartrate CAPSULE;ORAL 020823-005 Apr 21, 2000 ➤ Subscribe ➤ Subscribe
Novartis EXELON rivastigmine tartrate CAPSULE;ORAL 020823-003 Apr 21, 2000 ➤ Subscribe ➤ Subscribe
Novartis EXELON rivastigmine tartrate CAPSULE;ORAL 020823-006 Apr 21, 2000 ➤ Subscribe ➤ Subscribe
Novartis EXELON rivastigmine tartrate CAPSULE;ORAL 020823-003 Apr 21, 2000 ➤ Subscribe ➤ Subscribe
Novartis EXELON rivastigmine tartrate CAPSULE;ORAL 020823-005 Apr 21, 2000 ➤ Subscribe ➤ Subscribe
Novartis EXELON rivastigmine tartrate CAPSULE;ORAL 020823-004 Apr 21, 2000 ➤ Subscribe ➤ Subscribe
Novartis EXELON rivastigmine tartrate CAPSULE;ORAL 020823-004 Apr 21, 2000 ➤ Subscribe ➤ Subscribe
Novartis EXELON rivastigmine tartrate SOLUTION;ORAL 021025-001 Apr 21, 2000 ➤ Subscribe ➤ Subscribe
Novartis EXELON rivastigmine tartrate CAPSULE;ORAL 020823-006 Apr 21, 2000 ➤ Subscribe ➤ Subscribe
Novartis EXELON rivastigmine tartrate SOLUTION;ORAL 021025-001 Apr 21, 2000 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Chubb
Novartis
Harvard Business School
Covington
Johnson and Johnson
Argus Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot